Brain cells respond to neurotransmitters and psychoactive drugs through cell-specific receptor proteins. Studies on the integration of diverse signals in healthy and pathological conditions have focused on nitric oxide, cyclic nucleotide, and phosphoinositide pathways. The second messenger D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3, or IP3) binds stereospecifically to domains of membrane receptors to cause aggregation and opening of calcium channels. Several IP3 receptors (IP3R) have been cloned and expressed; establishing functional domains in homologous proteins is ongoing. Receptors and functions have been identified for other inositol polyphosphates and phosphoinostides; to date, however, the structures of proteins and binding domains specifically recognizing IP4, IP5, IP6, and the diphosphates IP7 and lP8 remain undetermined. Photoaffinity labels and immobilized affinity matrices will be developed in this proposal for proteins that bind specific inositol polyphosphates (IPn) from IP3 to IP7. These affinity probes will be prepared either from D-glucose or myo-inositol by stereospecific chemical synthesis of analogs selectively functionalized with a phosphodiester bearing an aminopropyl tether. For binding assays and visualization in electrophoretic gels, high specific activity tritium labels will be incorporated. Furthermore, synthesis of phosphatidyl inositol trisphosphate (PtdIns(3,4,5)P3, or PIP3) analogs, will be pursued to provide radioligands for the study of this new ligand. In addition, new synthetic routes to the inositol polyphosphate diphosphates such as IP7 will be developed. For each ligand prepared, the covalently-modified binding sites will be determined by protein digestion and amino acid sequencing. The structural biology of IPn - binding domain interactions will be explored using tools of molecular biology and biophysical chemistry. The phosphoinositide pathway has a pervasive impact in cellular biology, including calcium signaling, hormone signal transduction, odor and taste perception, neurotransmitter action, energy metabolism, protein phosphorylation, and protein trafficking. The affinity reagents and the binding domain data obtained from these reagents will be important in defining the mechanisms of these ubiquitous and varied molecular switches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS029632-09
Application #
2883652
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Sheridan, Philip
Project Start
1992-04-01
Project End
2000-02-29
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Utah
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Murph, Mandi M; Jiang, Guowei W; Altman, Molly K et al. (2015) Vinyl sulfone analogs of lysophosphatidylcholine irreversibly inhibit autotaxin and prevent angiogenesis in melanoma. Bioorg Med Chem 23:5999-6013
Jiang, Guowei; Madan, Damian; Prestwich, Glenn D (2011) Aromatic phosphonates inhibit the lysophospholipase D activity of autotaxin. Bioorg Med Chem Lett 21:5098-101
He, Ju; Gajewiak, Joanna; Scott, Jordan L et al. (2011) Metabolically stabilized derivatives of phosphatidylinositol 4-phosphate: synthesis and applications. Chem Biol 18:1312-9
Inoue, Asuka; Arima, Naoaki; Ishiguro, Jun et al. (2011) LPA-producing enzyme PA-PLA?? regulates hair follicle development by modulating EGFR signalling. EMBO J 30:4248-60
Zhang, Honglu; He, Ju; Kutateladze, Tatiana G et al. (2010) 5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration. Chembiochem 11:388-95
Best, Michael D; Zhang, Honglu; Prestwich, Glenn D (2010) Inositol polyphosphates, diphosphoinositol polyphosphates and phosphatidylinositol polyphosphate lipids: structure, synthesis, and development of probes for studying biological activity. Nat Prod Rep 27:1403-30
Xu, Xiaoyu; Prestwich, Glenn D (2010) Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three-dimensional lung cancer xenograft model. Cancer 116:1739-50
Altman, Molly K; Gopal, Vashisht; Jia, Wei et al. (2010) Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Mol Cancer 9:140
Morrison, B H; Haney, R; Lamarre, E et al. (2009) Gene deletion of inositol hexakisphosphate kinase 2 predisposes to aerodigestive tract carcinoma. Oncogene 28:2383-92
Xu, Xiaoyu; Yang, Guanghui; Zhang, Honglu et al. (2009) Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors. Prostaglandins Other Lipid Mediat 89:140-6

Showing the most recent 10 out of 108 publications